{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27186994", "DateCompleted": {"Year": "2017", "Month": "08", "Day": "11"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "05", "Day": "26"}], "ELocationID": ["10.1021/acs.jcim.5b00739"], "Language": ["eng"], "Journal": {"ISSN": "1549-960X", "JournalIssue": {"Volume": "56", "Issue": "6", "PubDate": {"Year": "2016", "Month": "Jun", "Day": "27"}}, "Title": "Journal of chemical information and modeling", "ISOAbbreviation": "J Chem Inf Model"}, "ArticleTitle": "Difference and Influence of Inactive and Active States of Cannabinoid Receptor Subtype CB2: From Conformation to Drug Discovery.", "Pagination": {"StartPage": "1152", "EndPage": "1163", "MedlinePgn": "1152-63"}, "Abstract": {"AbstractText": ["Cannabinoid receptor 2 (CB2), a G protein-coupled receptor (GPCR), is a promising target for the treatment of neuropathic pain, osteoporosis, immune system, cancer, and drug abuse. The lack of an experimental three-dimensional CB2 structure has hindered not only the development of studies of conformational differences between the inactive and active CB2 but also the rational discovery of novel functional compounds targeting CB2. In this work, we constructed models of both inactive and active CB2 by homology modeling. Then we conducted two comparative 100 ns molecular dynamics (MD) simulations on the two systems-the active CB2 bound with both the agonist and G protein and the inactive CB2 bound with inverse agonist-to analyze the conformational difference of CB2 proteins and the key residues involved in molecular recognition. Our results showed that the inactive CB2 and the inverse agonist remained stable during the MD simulation. However, during the MD simulations, we observed dynamical details about the breakdown of the \"ionic lock\" between R131(3.50) and D240(6.30) as well as the outward/inward movements of transmembrane domains of the active CB2 that bind with G proteins and agonist (TM5, TM6, and TM7). All of these results are congruent with the experimental data and recent reports. Moreover, our results indicate that W258(6.48) in TM6 and residues in TM4 (V164(4.56)-L169(4.61)) contribute greatly to the binding of the agonist on the basis of the binding energy decomposition, while residues S180-F183 in extracellular loop 2 (ECL2) may be of importance in recognition of the inverse agonist. Furthermore, pharmacophore modeling and virtual screening were carried out for the inactive and active CB2 models in parallel. Among all 10 hits, two compounds exhibited novel scaffolds and can be used as novel chemical probes for future studies of CB2. Importantly, our studies show that the hits obtained from the inactive CB2 model mainly act as inverse agonist(s) or neutral antagonist(s) at low concentration. Moreover, the hit from the active CB2 model also behaves as a neutral antagonist at low concentration. Our studies provide new insight leading to a better understanding of the structural and conformational differences between two states of CB2 and illuminate the effects of structure on virtual screening and drug design."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, NIH National Center of Excellence for Computational Drug Abuse Research, Drug Discovery Institute, and Department of Computational Biology and Structural Biology, School of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania 15260, United States."}, {"Identifier": [], "Affiliation": "College of Chemistry, Leshan Normal University , Leshan, Sichuan 614004, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy and Bioengineering; Key Laboratory of Medicinal and Edible Plants Resources Development, Chengdu University , Chengdu, Sichuan 610106, China."}], "LastName": "Hu", "ForeName": "Jianping", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, NIH National Center of Excellence for Computational Drug Abuse Research, Drug Discovery Institute, and Department of Computational Biology and Structural Biology, School of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania 15260, United States."}], "LastName": "Feng", "ForeName": "Zhiwei", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, NIH National Center of Excellence for Computational Drug Abuse Research, Drug Discovery Institute, and Department of Computational Biology and Structural Biology, School of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania 15260, United States."}], "LastName": "Ma", "ForeName": "Shifan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, NIH National Center of Excellence for Computational Drug Abuse Research, Drug Discovery Institute, and Department of Computational Biology and Structural Biology, School of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania 15260, United States."}], "LastName": "Zhang", "ForeName": "Yu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, NIH National Center of Excellence for Computational Drug Abuse Research, Drug Discovery Institute, and Department of Computational Biology and Structural Biology, School of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania 15260, United States."}], "LastName": "Tong", "ForeName": "Qin", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, NIH National Center of Excellence for Computational Drug Abuse Research, Drug Discovery Institute, and Department of Computational Biology and Structural Biology, School of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania 15260, United States."}], "LastName": "Alqarni", "ForeName": "Mohammed Hamed", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy and Bioengineering; Key Laboratory of Medicinal and Edible Plants Resources Development, Chengdu University , Chengdu, Sichuan 610106, China."}], "LastName": "Gou", "ForeName": "Xiaojun", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, NIH National Center of Excellence for Computational Drug Abuse Research, Drug Discovery Institute, and Department of Computational Biology and Structural Biology, School of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania 15260, United States."}], "LastName": "Xie", "ForeName": "Xiang-Qun", "Initials": "XQ"}], "GrantList": [{"GrantID": "P30 DA035778", "Acronym": "DA", "Agency": "NIDA NIH HHS", "Country": "United States"}, {"GrantID": "R01 DA025612", "Acronym": "DA", "Agency": "NIDA NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Chem Inf Model", "NlmUniqueID": "101230060", "ISSNLinking": "1549-9596"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Ligands"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptor, Cannabinoid, CB2"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Drug Discovery"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": [], "DescriptorName": "Protein Conformation"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Receptor, Cannabinoid, CB2"}, {"QualifierName": [], "DescriptorName": "Sequence Homology, Amino Acid"}, {"QualifierName": [], "DescriptorName": "Thermodynamics"}, {"QualifierName": [], "DescriptorName": "User-Computer Interface"}], "CoiStatement": "The authors declare no competing financial interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Salon JA, Lodowski DT, Palczewski K. The Significance of G Protein-Coupled Receptor Crystallography for Drug Discovery. Pharmacol Rev. 2011;63:901\u2013937.", "ArticleIdList": ["PMC3186081", "21969326"]}, {"Citation": "Wenthur CJ, Gentry PR, Mathews TP, Lindsley CW. Drugs for Allosteric Sites on Receptors. Annu Rev Pharmacol Toxicol. 2014;54:165.", "ArticleIdList": ["PMC4063350", "24111540"]}, {"Citation": "Feng Z, Kochanek S, Close D, Wang L, Srinivasan A, Almehizia AA, Iyer P, Xie XQ, Johnston PA, Gold B. Design and activity of AP endonuclease-1 inhibitors. J Chem Biol. 2015;8:79\u201393.", "ArticleIdList": ["PMC4470991", "26101550"]}, {"Citation": "Vemuri VK, Janero DR, Makriyannis A. Pharmacotherapeutic Targeting of the Endocannabinoid Signaling System: Drugs for Obesity and the Metabolic Syndrome. Physiol Behav. 2008;93:671\u2013686.", "ArticleIdList": ["PMC3681125", "18155257"]}, {"Citation": "Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrie B, Rinaldi-Carmona M, Calandra B, Le Fur G, Casellas P. Signaling Pathway Associated with Stimulation of CB2 Peripheral Cannabinoid Receptor. Involvement of both Mitogen-Activated Protein Kinase and Induction of Krox-24 Expression. Eur J Biochem. 1996;237:704\u2013711.", "ArticleIdList": ["8647116"]}, {"Citation": "Zhang HY, Gao M, Liu QR, Bi GH, Li X, Yang HJ, Gardner EL, Wu J, Xi ZX. Cannabinoid CB2 Receptors Modulate Midbrain Dopamine Neuronal Activity and Dopamine-Related Behavior in Mice. Proc Natl Acad Sci U S A. 2014;111:E5007\u2013E5015.", "ArticleIdList": ["PMC4246322", "25368177"]}, {"Citation": "Huffman JW, Marriott KSC. Recent Advances in the Development of Selective Ligands for the Cannabinoid CB(2) Receptor. Curr Top Med Chem. 2008;8:187\u2013204.", "ArticleIdList": ["18289088"]}, {"Citation": "Poso A, Huffman JW. Targeting the Cannabinoid CB2 Receptor: Modelling and Structural Determinants of CB2 Selective Ligands. Br J Pharmacol. 2008;153:335\u2013346.", "ArticleIdList": ["PMC2219524", "17982473"]}, {"Citation": "Reggio PH. Computational Methods in Drug Design: Modeling G Protein-Coupled Receptor Monomers, Dimers, and Oligomers. AAPS J. 2006;8:E322\u2013336.", "ArticleIdList": ["PMC3231557", "16796383"]}, {"Citation": "Song ZH, Slowey CA, Hurst DP, Reggio PH. The Difference between the CB1 and CB2 Cannabinoid Receptors at Position 5.46 Is Crucial for the Selectivity of WIN55212\u20132 for CB2. Mol Pharmacol. 1999;56:834\u2013840.", "ArticleIdList": ["10496968"]}, {"Citation": "Gouldson P, Calandra B, Legoux P, Kern\u00e9is A, Rinaldi-Carmona M, Barth F, Le Fur G, Ferrara P, Shire D. Mutational Analysis and Molecular Modelling of the Antagonist SR 144528 Binding Site on the Human Cannabinoid CB2 Receptor. Eur J Pharmacol. 2000;401:17\u201325.", "ArticleIdList": ["10915832"]}, {"Citation": "Chen JZ, Wang J, Xie XQ. GPCR Structure-Based Virtual Screening Approach for CB2 Antagonist Search. J Chem Inf Model. 2007;47:1626\u20131637.", "ArticleIdList": ["17580929"]}, {"Citation": "Feng Z, Alqarni MH, Yang P, Tong Q, Chowdhury A, Wang L, Xie XQ. Modeling, Molecular Dynamics Simulation, and Mutation Validation for Structure of Cannabinoid Receptor 2 Based on Known Crystal Structures of GPCRs. J Chem Inf Model. 2014;54:2483\u20132499.", "ArticleIdList": ["PMC4170816", "25141027"]}, {"Citation": "Xie XQ, Chen JZ, Billings EM. 3D Structural Model of the G-Protein-Coupled Cannabinoid CB2 Receptor. Proteins: Struct, Funct Genet. 2003;53:307\u2013319.", "ArticleIdList": ["14517981"]}, {"Citation": "Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M. Crystal Structure of Rhodopsin: AG Protein-Coupled Receptor. Science. 2000;289:739\u2013745.", "ArticleIdList": ["10926528"]}, {"Citation": "Tuccinardi T, Ferrarini PL, Manera C, Ortore G, Saccomanni G, Martinelli A. Cannabinoid CB2/CB1 Selectivity. Receptor Modeling and Automated Docking Analysis. J Med Chem. 2006;49:984\u2013994.", "ArticleIdList": ["16451064"]}, {"Citation": "Stern E, Muccioli GG, Millet R, Goossens JF, Farce A, Chavatte P, Poupaert JH, Lambert DM, Depreux P, H\u00e9nichart JP. Novel 4-oxo-1, 4-dihydroquinoline-3-carboxamide Derivatives as new CB2 Cannabinoid Receptors Agonists: Synthesis, Pharmacological Properties and Molecular Modeling. J Med Chem. 2006;49:70\u201379.", "ArticleIdList": ["16392793"]}, {"Citation": "Raduner S, Majewska A, Chen JZ, Xie XQ, Hamon J, Faller B, Altmann KH, Gertsch J. Alkylamides from Echinacea Are a new Class of Cannabinomimetics Cannabinoid Type 2 Receptor-Dependent and-Independent Immunomodulatory Effects. J Biol Chem. 2006;281:14192\u201314206.", "ArticleIdList": ["16547349"]}, {"Citation": "Venkatakrishnan A, Deupi X, Lebon G, Tate CG, Schertler GF, Babu MM. Molecular Signatures of G-Protein-Coupled Receptors. Nature. 2013;494:185\u2013194.", "ArticleIdList": ["23407534"]}, {"Citation": "Manglik A, Kobilka B. The Role of Protein Dynamics in GPCR Function: Insights from the \u03b2 2 AR and Rhodopsin. Curr Opin Cell Biol. 2014;27:136\u2013143.", "ArticleIdList": ["PMC3986065", "24534489"]}, {"Citation": "Bhattacharya S, Hall SE, Vaidehi N. Agonist-Induced Conformational Changes in Bovine Rhodopsin: Insight into Activation of G-Protein-Coupled Receptors. J Mol Biol. 2008;382:539\u2013555.", "ArticleIdList": ["18638482"]}, {"Citation": "Daga PR, Zaveri NT. Homology Modeling and Molecular Dynamics Simulations of the Active State of the Nociceptin Receptor Reveal new Insights into Agonist Binding and Activation. Proteins: Struct, Funct Genet. 2012;80:1948\u20131961.", "ArticleIdList": ["PMC3393802", "22489047"]}, {"Citation": "Mnpotra JS, Qiao Z, Cai J, Lynch DL, Grossfield A, Leioatts N, Hurst DP, Pitman MC, Song ZH, Reggio PH. Structural Basis of G Protein-Coupled Receptor-Gi Protein Interaction Formation of the Cannabinoid CB2 Receptor-Gi Protein Complex. J Biol Chem. 2014;289:20259\u201320272.", "ArticleIdList": ["PMC4106340", "24855641"]}, {"Citation": "Rasmussen SG, DeVree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, Thian FS, Chae PS, Pardon E, Calinski D, et al. Crystal Structure of the [bgr] 2 Adrenergic Receptor-Gs Protein Complex. Nature. 2011;477:549\u2013555.", "ArticleIdList": ["PMC3184188", "21772288"]}, {"Citation": "Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC. High-Resolution Crystal Structure of an Engineered Human \u03b22-Adrenergic G Protein\u2013Coupled Receptor. Science. 2007;318:1258\u20131265.", "ArticleIdList": ["PMC2583103", "17962520"]}, {"Citation": "Wall MA, Coleman DE, Lee E, I\u00f1iguez-Lluhi JA, Posner BA, Gilman AG, Sprang SR. The Structure of the G Protein Heterotrimer G i\u03b11 \u03b2 1 \u03b3 2. Cell. 1995;83:1047\u20131058.", "ArticleIdList": ["8521505"]}, {"Citation": "SYBYL-X, version 1.3. Tripos International; St. Louis, MO: 2010."}, {"Citation": "Mart\u00ed-Renom MA, Stuart AC, Fiser A, S\u00e1nchez R, Melo F, \u0160ali A. Comparative Protein Structure Modeling of Genes and Genomes. Annu Rev Biophys Biomol Struct. 2000;29:291\u2013325.", "ArticleIdList": ["10940251"]}, {"Citation": "Feng Z, Pearce LV, Xu X, Yang X, Yang P, Blumberg PM, Xie XQ. Structural Insight into Tetrameric hTRPV1 from Homology Modeling, Molecular Docking, Molecular Dynamics Simulation, Virtual Screening and Bioassay Validations. J Chem Inf Model. 2015;55:572\u2013588.", "ArticleIdList": ["PMC4508124", "25642729"]}, {"Citation": "Wiederstein M, Sippl MJ. ProSA-Web: Interactive Web Wervice for the Recognition of Errors in Three-Dimensional Structures of Proteins. Nucleic Acids Res. 2007;35:W407\u2013W410.", "ArticleIdList": ["PMC1933241", "17517781"]}, {"Citation": "Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a Program to Check the Stereochemical Qality of Protein Structures. J Appl Crystallogr. 1993;26:283\u2013291."}, {"Citation": "Jain AN. Scoring Noncovalent Protein-Ligand Interactions: a Continuous Differentiable Function Tuned to Compute Binding Affinities. J Comput-Aided Mol Des. 1996;10:427\u2013440.", "ArticleIdList": ["8951652"]}, {"Citation": "Pedretti A, Villa L, Vistoli G. VEGA: a Versatile Program to Convert, Handle and Visualize Molecular Structure on Windows-Based PCs. J Mol Graphics Modell. 2002;21:47\u201349.", "ArticleIdList": ["12413030"]}, {"Citation": "S\u00f8ndergaard CR, Olsson MH, Rostkowski M, Jensen JH. Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of p K a Values. J Chem Theory Comput. 2011;7:2284\u20132295.", "ArticleIdList": ["26606496"]}, {"Citation": "Hsin J, Arkhipov A, Yin Y, Stone JE, Schulten K. Using VMD: an Introductory Tutorial. Curr Protoc Bioinform. 2008;24:5.7.1\u20135.7.48.", "ArticleIdList": ["PMC2972669", "19085979"]}, {"Citation": "Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of Simple Potential Functions for Simulating Liquid Water. J Chem Phys. 1983;79:926."}, {"Citation": "Kal\u00e9 L, Skeel R, Bhandarkar M, Brunner R, Gursoy A, Krawetz N, Phillips J, Shinozaki A, Varadarajan K, Schulten K. NAMD2: Greater Scalability for Parallel Molecular Dynamics. J Comput Phys. 1999;151:283\u2013312."}, {"Citation": "Hou T, Wang J, Li Y, Wang W. Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations. J Chem Inf Model. 2011;51:69\u201382.", "ArticleIdList": ["PMC3029230", "21117705"]}, {"Citation": "Hou T, Yu R. Molecular Dynamics and Free Energy Studies on the Wild-Type and Double Mutant HIV-1 Protease Complexed with Amprenavir and two Amprenavir-Related Inhibitors: Mechanism for Binding and Drug Resistance. J Med Chem. 2007;50:1177\u20131188.", "ArticleIdList": ["17300185"]}, {"Citation": "Xu L, Li Y, Li D, Xu P, Tian S, Sun H, Liu H, Hou T. Exploring the Binding Mechanisms of MIF to CXCR2 using Theoretical Approaches. Phys Chem Chem Phys. 2015;17:3370\u20133382.", "ArticleIdList": ["25526079"]}, {"Citation": "Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A Smooth Particle Mesh Ewald Method. J Chem Phys. 1995;103:8577\u20138593."}, {"Citation": "Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, Chong L, Lee M, Lee T, Duan Y, Wang W, et al. Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Continuum Models. Acc Chem Res. 2000;33:889\u2013897.", "ArticleIdList": ["11123888"]}, {"Citation": "Tsui V, Case DA. Theory and Applications of the Generalized Born Solvation Model in Macromolecular Simulations. Biopolymers. 2000;56:275\u2013291.", "ArticleIdList": ["11754341"]}, {"Citation": "Bashford D, Case DA. Generalized Born Models of Macromolecular Solvation Effects. Annu Rev Phys Chem. 2000;51:129\u2013152.", "ArticleIdList": ["11031278"]}, {"Citation": "Sitkoff D, Sharp KA, Honig B. Accurate Calculation of Hydration Free Energies using Macroscopic Solvent Models. J Phys Chem. 1994;98:1978\u20131988."}, {"Citation": "Still WC, Tempczyk A, Hawley RC, Hendrickson T. Semianalytical Treatment of Solvation for Molecular Mechanics and Dynamics. J Am Chem Soc. 1990;112:6127\u20136129."}, {"Citation": "Weiser J, Shenkin PS, Still WC. Approximate Atomic Surfaces from Linear Combinations of Pairwise Overlaps (LCPO) J Comput Chem. 1999;20:217\u2013230."}, {"Citation": "Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A. Beta-Caryophyllene is a Dietary Cannabinoid. Proc Natl Acad Sci U S A. 2008;105:9099\u20139104.", "ArticleIdList": ["PMC2449371", "18574142"]}, {"Citation": "Yang P, Myint KZ, Tong Q, Feng R, Cao H, Almehizia AA, Alqarni MH, Wang L, Bartlow P, Gao Y, Gertsch J, Teramachi J, Kurihara N, Roodman GD, Cheng T, Xie XQ. Lead Discovery, Chemistry Optimization and Biological Evaluation Studies of Novel Bi-Amide Derivatives as CB2 Receptor Inverse Agonists and Osteoclast Inhibitors. J Med Chem. 2012;55:9973\u20139987.", "ArticleIdList": ["PMC3967745", "23072339"]}, {"Citation": "Zhang Y, Xie Z, Wang L, Schreiter B, Lazo JS, Gertsch J, Xie XQ. Mutagenesis and Computer Modeling Studies of a GPCR Conserved Residue W5. 43 (194) in Ligand Recognition and Signal Transduction for CB2 Receptor. Int Immunopharmacol. 2011;11:1303\u20131310.", "ArticleIdList": ["PMC3445262", "21539938"]}, {"Citation": "Yang P, Wang L, Feng R, Almehizia AA, Tong Q, Myint KZ, Ouyang Q, Alqarni MH, Wang L, Xie XQ. Novel Triaryl Sulfonamide Derivatives as Selective Cannabinoid Receptor 2 Inverse Agonists and Osteoclast Inhibitors: Discovery, Optimization, and Biological Evaluation. J Med Chem. 2013;56:2045\u20132058.", "ArticleIdList": ["PMC3967766", "23406429"]}, {"Citation": "Singh R, Hurst DP, Barnett-Norris J, Lynch D, Reggio PH, Guarnieri F. Activation of the Cannabinoid CB1 Receptor may Involve a W6. 48/F3. 36 Rotamer Toggle Switch. J Pept Res. 2002;60:357\u2013370.", "ArticleIdList": ["12464114"]}, {"Citation": "Feng Z, Hou T, Li Y. Selectivity and Activation of Dopamine D3R from Molecular Dynamics. J Mol Model. 2012;18:5051\u20135063.", "ArticleIdList": ["22752545"]}, {"Citation": "Smart OS, Neduvelil JG, Wang X, Wallace B, Sansom MS. HOLE: a Program for the Analysis of the Pore Dimensions of Ion Channel Structural Models. J Mol Graphics. 1996;14:354\u2013360.", "ArticleIdList": ["9195488"]}, {"Citation": "Bai Q, P\u00e9rez-S\u00e1nchez H, Zhang Y, Shao Y, Shi D, Liu H, Yao X. Ligand Induced Change of \u03b2 2 Adrenergic Receptor from Active to Inactive Conformation and its Implication for the Closed/ Open State of the Water Channel: Insight from Molecular Dynamics Simulation, Free Energy Calculation and Markov State Model Analysis. Phys Chem Chem Phys. 2014;16:15874\u201315885.", "ArticleIdList": ["24962153"]}, {"Citation": "Feng Z, Hou T, Li Y. Studies on the Interactions between \u03b22 Adrenergic Receptor and Gs Protein by Molecular Dynamics Simulations. J Chem Inf Model. 2012;52:1005\u20131014.", "ArticleIdList": ["22404225"]}, {"Citation": "Hurst DP, Grossfield A, Lynch DL, Feller S, Romo TD, Gawrisch K, Pitman MC, Reggio PH. A Lipid Pathway for Ligand Binding is Necessary for a Cannabinoid G Protein-Coupled Receptor. J Biol Chem. 2010;285:17954\u201317964.", "ArticleIdList": ["PMC2878557", "20220143"]}, {"Citation": "Kapur A, Hurst DP, Fleischer D, Whitnell R, Thakur GA, Makriyannis A, Reggio PH, Abood ME. Mutation Studies of Ser7. 39 and Ser2. 60 in the Human CB1 Cannabinoid Receptor: Evidence for a Serine-Induced Bend in CB1 Transmembrane Helix 7. Mol Pharmacol. 2007;71:1512\u20131524.", "ArticleIdList": ["17384224"]}, {"Citation": "Xu L, Li D, Tao L, Yang Y, Li Y, Hou T. Binding Mechanisms of 1, 4-dihydropyridine Derivatives to L-type Calcium Channel Ca v 1.2: a Molecular Modeling Study. Mol BioSyst. 2016;12:379\u2013390.", "ArticleIdList": ["26673131"]}, {"Citation": "Xu L, Zhang Y, Zheng L, Qiao C, Li Y, Li D, Zhen X, Hou T. Discovery of Novel Inhibitors Sargeting the Macrophage Migration Inhibitory Factor via Structure-Based Virtual Screening and Bioassays. J Med Chem. 2014;57:3737\u20133745.", "ArticleIdList": ["24712915"]}, {"Citation": "Nebane NM, Hurst DP, Carrasquer CA, Qiao Z, Reggio PH, Song ZH. Residues Accessible in the Binding-Site Crevice of Transmembrane Helix 6 of the CB2 Cannabinoid Receptor\u2020. Biochemistry. 2008;47:13811\u201313821.", "ArticleIdList": ["PMC4791095", "19053233"]}, {"Citation": "Louet M, Martinez J, Floquet N. GDP Release Preferentially Occurs on the Phosphate Side in Heterotrimeric G-Proteins. PLoS Comput Biol. 2012;8:e1002595.", "ArticleIdList": ["PMC3400569", "22829757"]}, {"Citation": "Deupi X, Kobilka BK. Energy Landscapes as a Tool to Integrate GPCR Structure, Dynamics, and Function. Physiology. 2010;25:293\u2013303.", "ArticleIdList": ["PMC3056154", "20940434"]}, {"Citation": "Kofuku Y, Ueda T, Okude J, Shiraishi Y, Kondo K, Maeda M, Tsujishita H, Shimada I. Efficacy of the \u03b22-Adrenergic Receptor is Determined by Conformational Equilibrium in the Transmembrane Region. Nat Commun. 2012;3:1045.", "ArticleIdList": ["PMC3658005", "22948827"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "5", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "5", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "27"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27186994", "NIHMS849580", "PMC5395206", "10.1021/acs.jcim.5b00739"]}}], "PubmedBookArticle": []}